83220-74-0

Basic information

• Product Name: tert-butyl 3-phenoxypyrrolidine-1-carboxylate
• Synonyms: tert-butyl 3-phenoxypyrrolidine-1-carboxylate
• CAS NO: 83220-74-0
• Molecular Weight: 263.337
• Mol File: 83220-74-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl 3-phenoxypyrrolidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-phenoxypyrrolidine-1-carboxylate(83220-74-0)
• EPA Substance Registry System: tert-butyl 3-phenoxypyrrolidine-1-carboxylate(83220-74-0)

Safety Data

• Hazardous Substances Data: 83220-74-0(Hazardous Substances Data)

Upstream product

• 16156-59-5 phenyl methanesulfonate 
• 103057-44-9 N-(tert-butoxycarbonyl)-3-hydroxypyrrolidine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 58632-95-4 2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile 
• 108-95-2 phenol 

Downstream Products

• 1366664-52-9 C₁₀H₁₃NO*(x)ClH 
• 21767-15-7 3-phenoxypyrrolidine hydrochloride 
• 83220-81-9 3-Phenoxy-pyrrolidine; compound with trifluoro-acetic acid 

Relevant articles and documents

SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES

This application discloses compounds according to generic Formula (I): wherein all variables are defined as described herein which exhibit strong inhibition effects on various cancer cell lines. The compounds disclosed herein are useful for the treatment of proliferative diseases, including neoplastic diseases such as cancer and non- neoplastic disorders such as rheumatoid arthritis. Also disclosed are pharmaceutical compositions containing compounds of Formula (I) and at least one carrier, diluent or excipient and optionally one or more additional therapeutically active agents, including anticancer agents. This application also discloses methods for treating a proliferative disease, including neoplastic diseases such as cancer and non- neoplastic disorders such as rheumatoid arthritis.

NOVEL HETEROCYCLIC ACRYLAMIDES AND THEIR USE AS PHARMACEUTICALS

The invention relates to novel heterocyclic acrylamide compounds (I), to the preparation of the compounds and intermediates used therein, to the use of the compounds as antibacterial medicaments and pharmaceutical compositions containing the compounds.